Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy Service, Hospital | 6 | 2022 | 90 | 3.870 |
Why?
|
| Critical Illness | 10 | 2022 | 755 | 3.430 |
Why?
|
| Shock, Septic | 5 | 2021 | 207 | 2.550 |
Why?
|
| Pharmacists | 9 | 2022 | 246 | 2.450 |
Why?
|
| Intensive Care Units | 10 | 2022 | 734 | 2.090 |
Why?
|
| Pharmacy | 3 | 2021 | 30 | 1.610 |
Why?
|
| Critical Care | 8 | 2021 | 550 | 1.300 |
Why?
|
| Mentors | 2 | 2021 | 178 | 1.260 |
Why?
|
| Pharmaceutical Services | 3 | 2021 | 81 | 0.930 |
Why?
|
| Education, Pharmacy | 3 | 2020 | 119 | 0.920 |
Why?
|
| Norepinephrine | 2 | 2021 | 209 | 0.850 |
Why?
|
| Students, Pharmacy | 3 | 2020 | 96 | 0.820 |
Why?
|
| Community Pharmacy Services | 1 | 2021 | 43 | 0.730 |
Why?
|
| Peptic Ulcer | 1 | 2020 | 18 | 0.710 |
Why?
|
| Medication Reconciliation | 1 | 2020 | 29 | 0.690 |
Why?
|
| APACHE | 1 | 2020 | 65 | 0.690 |
Why?
|
| Vasoconstrictor Agents | 4 | 2021 | 125 | 0.680 |
Why?
|
| Hypotension | 1 | 2021 | 115 | 0.670 |
Why?
|
| Sepsis | 3 | 2020 | 562 | 0.650 |
Why?
|
| Anesthesia | 1 | 2021 | 129 | 0.650 |
Why?
|
| Drug Therapy | 1 | 2019 | 77 | 0.610 |
Why?
|
| Medication Therapy Management | 1 | 2019 | 72 | 0.590 |
Why?
|
| Mentoring | 1 | 2020 | 130 | 0.570 |
Why?
|
| Fluid Therapy | 5 | 2021 | 134 | 0.550 |
Why?
|
| Machine Learning | 1 | 2020 | 442 | 0.490 |
Why?
|
| Electronic Health Records | 1 | 2022 | 973 | 0.460 |
Why?
|
| Patient Care Team | 1 | 2019 | 597 | 0.460 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 886 | 0.430 |
Why?
|
| Humans | 34 | 2024 | 128019 | 0.430 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 536 | 0.400 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2021 | 26 | 0.400 |
Why?
|
| Hospital Mortality | 3 | 2020 | 844 | 0.360 |
Why?
|
| Heart Failure | 2 | 2020 | 2141 | 0.340 |
Why?
|
| Retrospective Studies | 8 | 2024 | 14404 | 0.330 |
Why?
|
| Professional Role | 2 | 2021 | 156 | 0.310 |
Why?
|
| Enterococcus faecalis | 1 | 2024 | 27 | 0.220 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2024 | 65 | 0.210 |
Why?
|
| Patient Discharge | 2 | 2020 | 850 | 0.210 |
Why?
|
| Bacteremia | 1 | 2024 | 192 | 0.190 |
Why?
|
| Sexual Harassment | 1 | 2021 | 26 | 0.190 |
Why?
|
| Pharmacies | 1 | 2021 | 36 | 0.180 |
Why?
|
| Claudin-5 | 1 | 2021 | 2 | 0.180 |
Why?
|
| Atracurium | 1 | 2021 | 14 | 0.180 |
Why?
|
| Water-Electrolyte Balance | 1 | 2021 | 32 | 0.180 |
Why?
|
| Hospitalization | 2 | 2021 | 2057 | 0.180 |
Why?
|
| Vasopressins | 1 | 2021 | 64 | 0.180 |
Why?
|
| Faculty, Pharmacy | 1 | 2020 | 20 | 0.170 |
Why?
|
| Angiotensin II | 1 | 2020 | 93 | 0.170 |
Why?
|
| Microvessels | 1 | 2021 | 79 | 0.170 |
Why?
|
| Efficiency | 1 | 2020 | 91 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 35176 | 0.170 |
Why?
|
| Shock | 1 | 2020 | 92 | 0.160 |
Why?
|
| Resource Allocation | 1 | 2019 | 39 | 0.160 |
Why?
|
| Faculty | 1 | 2020 | 135 | 0.160 |
Why?
|
| Cadherins | 1 | 2021 | 186 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 478 | 0.160 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2019 | 21 | 0.160 |
Why?
|
| Models, Organizational | 1 | 2019 | 145 | 0.150 |
Why?
|
| Laryngeal Edema | 1 | 2018 | 1 | 0.150 |
Why?
|
| Patient Care | 1 | 2019 | 108 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2020 | 369 | 0.150 |
Why?
|
| Adenosine Monophosphate | 1 | 2019 | 62 | 0.150 |
Why?
|
| Length of Stay | 2 | 2024 | 1114 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 169 | 0.150 |
Why?
|
| Polypharmacy | 1 | 2019 | 84 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2021 | 481 | 0.150 |
Why?
|
| Delirium | 1 | 2019 | 78 | 0.150 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 86 | 0.150 |
Why?
|
| Resuscitation | 1 | 2020 | 234 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 524 | 0.140 |
Why?
|
| Minocycline | 1 | 2017 | 27 | 0.140 |
Why?
|
| Airway Extubation | 1 | 2018 | 54 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2020 | 270 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 854 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 186 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2019 | 149 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 246 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2019 | 226 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 424 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2021 | 1711 | 0.140 |
Why?
|
| Research | 1 | 2020 | 408 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 106 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 109 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 203 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2019 | 305 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 439 | 0.120 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 844 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1482 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2019 | 615 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 1689 | 0.110 |
Why?
|
| Research Design | 1 | 2019 | 1034 | 0.110 |
Why?
|
| Pain | 1 | 2019 | 748 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2024 | 10110 | 0.100 |
Why?
|
| Aged | 3 | 2024 | 21892 | 0.100 |
Why?
|
| Middle Aged | 4 | 2024 | 30812 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2703 | 0.090 |
Why?
|
| Administration, Intravenous | 2 | 2024 | 137 | 0.090 |
Why?
|
| Stroke | 1 | 2019 | 1063 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 7029 | 0.080 |
Why?
|
| Male | 5 | 2024 | 62757 | 0.070 |
Why?
|
| Educational Measurement | 2 | 2020 | 257 | 0.070 |
Why?
|
| Female | 4 | 2024 | 68016 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 600 | 0.060 |
Why?
|
| Curriculum | 2 | 2020 | 909 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 766 | 0.050 |
Why?
|
| Gender Identity | 1 | 2021 | 121 | 0.040 |
Why?
|
| Georgia | 1 | 2020 | 78 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 3874 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2019 | 28 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2024 | 663 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 197 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 371 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2018 | 120 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 264 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 495 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1454 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 961 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5378 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 16574 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 4006 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 5199 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2646 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5353 | 0.020 |
Why?
|
| Animals | 2 | 2021 | 34487 | 0.020 |
Why?
|
| United States | 1 | 2018 | 13785 | 0.010 |
Why?
|